
|Articles|October 1, 2019
- Applied Clinical Trials-10-01-2019
- Volume 28
- Issue 10
Applied Clinical Trials, October 2019 Issue (PDF)
Click the title above to open the Applied Clinical Trials October 2019 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 6 years ago
New Wrinkle in Outsourcing Viewsalmost 7 years ago
Operational Complexity in Cell and Gene Therapy Trialsalmost 7 years ago
Alzheimer’s Research Finds New Beginningsalmost 7 years ago
Eliminating ‘Disruption’ for Patients in Clinical Trialsalmost 7 years ago
Data Manipulation Case Spotlights Wider Concerns, Actionsalmost 7 years ago
Patient Experience Comes to Drug Developmentalmost 7 years ago
Industry Report on Outsourcing Spend, Models, and Measuresalmost 7 years ago
Fighting High Prices for Innovative Drugs with NHS Generic ProductionAdvertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Pauses Real-Time Release of Drug Rejection Letters While Working to Formalize Policy
2
ACT Brief: Single Pivotal Trial Stakes, Configurable FSP Strategy, and G-CSF Biosimilar Portfolio Expansion
3
Tailoring Your FSP Approach: Why One Model Doesn’t Fit Every Trial
4
Bringing the Voice of Clinical Practice and Patients into Drug Development
5




